{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:35:49Z","timestamp":1774107349226,"version":"3.50.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_153389"],"award-info":[{"award-number":["320030_153389"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31BL30_185396"],"award-info":[{"award-number":["31BL30_185396"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CANSEARCH Foundation"},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016067","name":"Fondation Charles-Bruneau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Genotype-phenotype analyses of rare diseases often suffer from a lack of power, due to small sample size, which makes identifying significant associations difficult. Sinusoidal obstruction syndrome (SOS) of the liver is a rare but life-threatening complication of hematopoietic stem cell transplantation (HSCT). The alkylating agent busulfan is commonly used in HSCT and known to trigger SOS. We developed a novel pipeline to identify genetic determinants in rare diseases by combining<jats:italic>in vitro<\/jats:italic>information with clinical whole-exome sequencing (WES) data and applied it in SOS patients and controls.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>First, we analysed differential gene expression in six lymphoblastoid cell lines (LCLs) before and after incubation with busulfan. Second, we used WES data from 87 HSCT patients and estimated the association with SOS at the SNP and the gene levels. We then combined the results of the expression and the association analyses into an association statistic at the gene level. We used an over-representation analysis to functionally characterize the genes that were associated with a significant combined test statistic.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>After treatment of LCLs with busulfan, 1708 genes were significantly up-, and 1385 down-regulated. The combination of the expression experiment and the association analysis of WES data into a single test statistic revealed 35 genes associated with the outcome. These genes are involved in various biological functions and processes, such as \u201c<jats:italic>Cell growth and death<\/jats:italic>\u201d, \u201c<jats:italic>Signalling molecules and interaction<\/jats:italic>\u201d, \u201c<jats:italic>Cancer<\/jats:italic>\u201d, and \u201c<jats:italic>Infectious disease<\/jats:italic>\u201d.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>This novel data analysis pipeline integrates two independent omics datasets and increases statistical power for identifying genotype-phenotype associations. The analysis of the transcriptomics profile of cell lines treated with busulfan and WES data from HSCT patients allowed us to identify potential genetic contributors to SOS. Our pipeline could be useful for identifying genetic contributors to other rare diseases where limited power renders genome-wide analyses unpromising.<\/jats:p><\/jats:sec><jats:sec id=\"sec005\"><jats:title>Trial registration<\/jats:title><jats:p>For the clinical dataset: Clinicaltrials.gov:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01257854\" xlink:type=\"simple\">NCT01257854<\/jats:ext-link>.<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/history\/NCT01257854\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/history\/NCT01257854<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0281892","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T18:07:37Z","timestamp":1680718057000},"page":"e0281892","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-8959","authenticated-orcid":true,"given":"Nicolas","family":"Waespe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2552-456X","authenticated-orcid":true,"given":"Simona Jurkovic","family":"Mlakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Dupanloup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Aziz","family":"Rezgui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-2002","authenticated-orcid":true,"given":"Claudia E.","family":"Kuehni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9649-6498","authenticated-orcid":true,"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"pone.0281892.ref001","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"KM Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"pone.0281892.ref002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease).","volume":"4","author":"CQ Fan","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"pone.0281892.ref003","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"GB McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"pone.0281892.ref004","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"S Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.","volume":"22","author":"J-H Dalle","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation."},{"key":"pone.0281892.ref006","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12887-020-02028-6","article-title":"Busulfan systemic exposure and its relationship with efficacy and safety in hematopoietic stem cell transplantation in children: a meta-analysis","volume":"20","author":"X Feng","year":"2020","journal-title":"BMC Pediatr"},{"key":"pone.0281892.ref007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jtct.2022.01.013","article-title":"Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.","volume":"28","author":"T Bogn\u00e0r","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"pone.0281892.ref008","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"IH Bartelink","year":"2016","journal-title":"The Lancet Haematology"},{"key":"pone.0281892.ref009","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.transproceed.2010.04.024","article-title":"Vascular endothelium changes after conditioning in hematopoietic stem cell transplantation: role of cyclophosphamide and busulfan","volume":"42","author":"L Zeng","year":"2010","journal-title":"Transplant Proc"},{"key":"pone.0281892.ref010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1700760","article-title":"Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation","volume":"19","author":"YD Park","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref011","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bmt.1702624","article-title":"Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study","volume":"26","author":"S Tanikawa","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0609.2000.9r200.x","article-title":"Veno-occlusive disease of the liver after hemopoietic cell transplantation","volume":"64","author":"E. Carreras","year":"2000","journal-title":"Eur J Haematol"},{"key":"pone.0281892.ref013","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41409-019-0474-8","article-title":"Systematic review of defibrotide studies in the treatment of veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS).","volume":"54","author":"P Richardson","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref014","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bjh.16552","article-title":"Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation","volume":"190","author":"PG Richardson","year":"2020","journal-title":"Br J Haematol"},{"key":"pone.0281892.ref015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"S Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"pone.0281892.ref016","doi-asserted-by":"crossref","first-page":"90852","DOI":"10.18632\/oncotarget.20310","article-title":"GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study","volume":"8","author":"M Ansari","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0281892.ref017","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"A Srivastava","year":"2004","journal-title":"Blood"},{"key":"pone.0281892.ref018","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bmt.2012.265","article-title":"Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients","volume":"48","author":"M Ansari","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref019","article-title":"Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation","author":"P Huezo-Diaz Curtis","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"pone.0281892.ref020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/bmt.2014.16","article-title":"MTHFR C677T\/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome","volume":"49","author":"E Efrati","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref021","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bmt.1704943","article-title":"The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"35","author":"AR Kallianpur","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref022","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbmt.2019.11.026","article-title":"Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.","volume":"26","author":"M Ansari","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"pone.0281892.ref023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/jpm11050347","article-title":"Genetic Predictors for Sinusoidal Obstruction Syndrome\u2014A Systematic Review","volume":"11","author":"N Waespe","year":"2021","journal-title":"Journal of Personalized Medicine"},{"key":"pone.0281892.ref024","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425250903107764","article-title":"Busulfan in hematopoietic stem cell transplant setting","volume":"5","author":"JS McCune","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"pone.0281892.ref025","doi-asserted-by":"crossref","first-page":"e1608","DOI":"10.1002\/mpr.1608","article-title":"A tutorial on conducting genome-wide association studies: Quality control and statistical analysis","volume":"27","author":"AT Marees","year":"2018","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"pone.0281892.ref026","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/thg.2014.79","article-title":"VEGAS2: Software for More Flexible Gene-Based Testing.","volume":"18","author":"A Mishra","year":"2015","journal-title":"Twin Res Hum Genet"},{"key":"pone.0281892.ref027","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1479-7364-4-5-353","article-title":"A survey of current software for network analysis in molecular biology","volume":"4","author":"S Thomas","year":"2010","journal-title":"Hum Genomics"},{"key":"pone.0281892.ref028","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biology"},{"key":"pone.0281892.ref029","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"pone.0281892.ref030","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1420-9101.2005.00917.x","article-title":"Combining probability from independent tests: the weighted Z-method is superior to Fisher\u2019s approach","volume":"18","author":"MC Whitlock","year":"2005","journal-title":"Journal of Evolutionary Biology"},{"key":"pone.0281892.ref031","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"M Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0281892.ref032","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"B Jassal","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"pone.0281892.ref033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"CM Lewis","year":"2020","journal-title":"Genome Medicine"},{"key":"pone.0281892.ref034","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)."},{"key":"pone.0281892.ref035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Y Benjamini","year":"2001","journal-title":"The Annals of Statistics"},{"key":"pone.0281892.ref036","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation.","volume":"78","author":"S Kumar","year":"2003","journal-title":"Mayo Clinic Proceedings"},{"key":"pone.0281892.ref037","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.leu.2402946","article-title":"Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation","volume":"17","author":"R Schots","year":"2003","journal-title":"Leukemia"},{"key":"pone.0281892.ref038","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00228-011-1209-y","article-title":"Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis","volume":"68","author":"J Reimer","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0281892.ref039","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3109\/10428194.2013.810739","article-title":"Busulfan directly inhibits T cell proliferation through non-anergic cell cycle arrest","volume":"55","author":"E Ben-Ami","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"pone.0281892.ref040","doi-asserted-by":"crossref","first-page":"e25294","DOI":"10.1097\/MD.0000000000025294","article-title":"Identification and validation of key non-coding RNAs and mRNAs using co-expression network analysis in pre-eclampsia.","volume":"100","author":"J He","year":"2021","journal-title":"Medicine (Baltimore)."},{"key":"pone.0281892.ref041","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"CE Powe","year":"2011","journal-title":"Circulation"},{"key":"pone.0281892.ref042","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.RES.0000146674.38319.07","article-title":"Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4\/CXCL4 and Potent Inhibitor of Angiogenesis.","volume":"95","author":"Struyf Sofie","year":"2004","journal-title":"Circulation Research"},{"key":"pone.0281892.ref043","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2009-11-253591","article-title":"Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.","volume":"117","author":"S Struyf","year":"2011","journal-title":"Blood"},{"key":"pone.0281892.ref044","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/imj.13550","article-title":"New insights into sinusoidal obstruction syndrome","volume":"47","author":"A Piccin","year":"2017","journal-title":"Intern Med J"},{"key":"pone.0281892.ref045","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2174\/1568009619666190620114928","article-title":"The Role of Shcbp1 in Signaling and Disease.","volume":"19","author":"G-Y Zhang","year":"2019","journal-title":"Curr Cancer Drug Targets"},{"key":"pone.0281892.ref046","doi-asserted-by":"crossref","first-page":"28485","DOI":"10.1074\/jbc.R109.042168","article-title":"CYP7B1: One Cytochrome P450, Two Human Genetic Diseases, and Multiple Physiological Functions","volume":"284","author":"AR Stiles","year":"2009","journal-title":"J Biol Chem"},{"key":"pone.0281892.ref047","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"447","author":"L He","year":"2007","journal-title":"Nature"},{"key":"pone.0281892.ref048","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1097-2765(01)00275-1","article-title":"Myc requires distinct E2F activities to induce S phase and apoptosis","volume":"8","author":"G Leone","year":"2001","journal-title":"Mol Cell"},{"key":"pone.0281892.ref049","doi-asserted-by":"crossref","first-page":"e64228","DOI":"10.1371\/journal.pone.0064228","article-title":"Transmembrane protein 208: a novel ER-localized protein that regulates autophagy and ER stress.","volume":"8","author":"Y Zhao","year":"2013","journal-title":"PLoS One"},{"key":"pone.0281892.ref050","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12015-020-10027-4","article-title":"Busulfan Suppresses Autophagy in Mouse Spermatogonial Progenitor Cells via mTOR of AKT and p53 Signaling Pathways.","volume":"16","author":"R Wei","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"pone.0281892.ref051","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.devcel.2020.01.031","article-title":"TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation","volume":"52","author":"O Sullivan GP","year":"2020","journal-title":"Developmental Cell"},{"key":"pone.0281892.ref052","first-page":"83546","article-title":"mRNA expression disturbance of complement system related genes in acute arterial thrombotic and paroxysmal atrial fibrillation patients","volume":"9","author":"S Wen","year":"2020","journal-title":"Annals of Palliative Medicine"},{"key":"pone.0281892.ref053","doi-asserted-by":"crossref","first-page":"e26963","DOI":"10.1002\/pbc.26963","article-title":"Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.","volume":"65","author":"M Mauro","year":"2018","journal-title":"Pediatr Blood Cancer."},{"key":"pone.0281892.ref054","first-page":"633","article-title":"Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile","volume":"18","author":"SL Goldberg","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.bmt.1702390","article-title":"Factor V Leiden mutation as a predisposing factor for veno-occlusive disease following BMT","volume":"25","author":"M Ertem","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"pone.0281892.ref056","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/jir.2007.0086","article-title":"Unique features of different members of the human guanylate-binding protein family","volume":"27","author":"P Tripal","year":"2007","journal-title":"J Interferon Cytokine Res"},{"key":"pone.0281892.ref057","doi-asserted-by":"crossref","first-page":"174317","DOI":"10.1016\/j.ejphar.2021.174317","article-title":"Involvement of miR-199a-3p\/DDR1 in vascular endothelial cell senescence in diabetes","volume":"908","author":"L Yan","year":"2021","journal-title":"European Journal of Pharmacology"},{"key":"pone.0281892.ref058","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardiores.2004.03.028","article-title":"The role of perlecan in arterial injury and angiogenesis","volume":"63","author":"A Segev","year":"2004","journal-title":"Cardiovascular Research"},{"key":"pone.0281892.ref059","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.molcel.2005.10.001","article-title":"Human DNA Polymerase \u03b7 Promotes DNA Synthesis from Strand Invasion Intermediates of Homologous Recombination","volume":"20","author":"MJ McIlwraith","year":"2005","journal-title":"Molecular Cell"},{"key":"pone.0281892.ref060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1139\/gen-2020-0131","article-title":"Machine learning for precision medicine","volume":"64","author":"SJ MacEachern","year":"2021","journal-title":"Genome"},{"key":"pone.0281892.ref061","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","article-title":"Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus","volume":"91","author":"MV Relling","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"pone.0281892.ref062","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.gde.2010.03.006","article-title":"Candidate gene association studies: Successes and failures","volume":"20","author":"B Pasche","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"pone.0281892.ref063","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biopsych.2006.11.010","article-title":"Spurious Genetic Associations.","volume":"61","author":"PF Sullivan","year":"2007","journal-title":"Biological Psychiatry"},{"key":"pone.0281892.ref064","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fgene.2018.00412","article-title":"Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response.","volume":"9","author":"J Pi\u00f1ero","year":"2018","journal-title":"Front Genet."},{"key":"pone.0281892.ref065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/pgs.11.121","article-title":"Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation","volume":"13","author":"HE Wheeler","year":"2012","journal-title":"Pharmacogenomics"},{"key":"pone.0281892.ref066","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lab.2005.10.005","article-title":"The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool","volume":"147","author":"C-C Liew","year":"2006","journal-title":"Journal of Laboratory and Clinical Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T19:44:36Z","timestamp":1729194276000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281892"}},"subtitle":[],"editor":[{"given":"Gary S.","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281892","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]}}}